Tag: fiscal year

FDA Orphan Products Grants are awarded based on rigorous scientific and technical review by rare disease and regulatory experts

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat and certain of Red Cat’s top current and former executives with violations of the Securities Exchange Act of 1934.

UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING

New York, NY , June 06, 2025 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (OTC Pink: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today that on June 5, 2025, it caused to be deposited $0.15 per public share, totaling $10,890.15 (the “Extension Payment”) into its trust account (the “Trust Account”) with Continental Stock Transfer and Trust Company (“Continental”) to extend the deadline to complete its initial business combination from June 9, 2025 to July 9, 2025. The extension is the twenty-fourth extension since the consummation of the Company’s initial public offering on December 9, 2021, and the first of up to six extensions permitted under the Company’s governing documents currently in effect.

DEERFIELD, Ill, June 06, 2025 (GLOBE NEWSWIRE) -- BAB, Inc. (OTCQB: BABB), today announced that its Board of Directors has declared a quarterly distribution of one cent ($0.01) per share, payable on July 14, 2025 to shareholders of record as of June 26, 2025.

INDIANAPOLIS, June 06, 2025 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the second fiscal quarter ended April 30, 2025. Hurco recorded a net loss of $4,063,000, or $0.62 per diluted share, for the second quarter of fiscal year 2025, which included a non-cash tax valuation allowance of $1,270,000 recorded in provision for income taxes. This net loss of $4,063,000 for the second quarter of fiscal 2025 compared to a net loss of $3,922,000, or $0.61 per diluted share, for the corresponding period in fiscal year 2024. For the first six months of fiscal year 2025, Hurco reported a net loss of $8,383,000, or $1.29 per diluted share, compared to a net loss of $5,570,000, or $0.86 per diluted share, for the corresponding period in fiscal year 2024. The net loss for the first six months of fiscal 2025 included $3,655,000 non-cash tax valuation allowance recorded in provision for income taxes.